Morning glory sign: a particular MR finding in progressive supranuclear palsy
- PMID: 16093629
- DOI: 10.2463/mrms.3.125
Morning glory sign: a particular MR finding in progressive supranuclear palsy
Abstract
Background and purpose: We have encountered a peculiar atrophic change in the midbrain in some patients with parkinsonian syndromes. We discovered these patients had vertical supranuclear gaze-palsy, an eye movement disorder. The purpose of this study was to elucidate whether this atrophic pattern of the midbrain (which we have termed morning glory sign) is related to the vertical eye movement disorder, in particular to progressive supranuclear palsy (PSP).
Methods: We reviewed T2-weighted axial images obtained from 42 patients with parkinsonian syndromes, including five patients with PSP, 23 patients with Parkinson's disease, and 14 patients with multiple system atrophy (MSA). We focused on a specific atrophy of the midbrain, the morning glory sign, which is a concavity of the lateral margin of the tegmentum of the midbrain.
Results: The morning glory sign was detected in four of the five patients with PSP and in one (striatonigral degeneration; SND) of the14 patients with MSA. All morning glory sign patients had vertical supranuclear gaze-palsy, as did the one PSP patient without the morning glory sign. Vertical supranuclear gaze-palsy was seen in no other patients (23 patients with Parkinson's disease and 13 patients with MSA) who lacked the morning glory sign.
Conclusions: Morphologically, the morning glory sign is believed to be related to vertical supranuclear gaze-palsy. This sign should be considered a useful clue when diagnosing PSP.
Comment in
-
Morning glory sign is not prevalent in progressive supranuclear palsy.Magn Reson Med Sci. 2004;3(4):215; author reply 216-7. doi: 10.2463/mrms.3.215. Magn Reson Med Sci. 2004. PMID: 16093641 No abstract available.
Similar articles
-
The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.Parkinsonism Relat Disord. 2018 Sep;54:90-94. doi: 10.1016/j.parkreldis.2018.04.005. Epub 2018 Apr 3. Parkinsonism Relat Disord. 2018. PMID: 29643007
-
Study of the rostral midbrain atrophy in progressive supranuclear palsy.J Neurol Sci. 2003 Jun 15;210(1-2):57-60. doi: 10.1016/s0022-510x(03)00014-5. J Neurol Sci. 2003. PMID: 12736089
-
Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.Neuroimage Clin. 2019;22:101722. doi: 10.1016/j.nicl.2019.101722. Epub 2019 Feb 19. Neuroimage Clin. 2019. PMID: 30831462 Free PMC article.
-
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.Neuroradiology. 2017 May;59(5):431-443. doi: 10.1007/s00234-017-1812-4. Epub 2017 Apr 6. Neuroradiology. 2017. PMID: 28386688 Review.
-
Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies.Dis Mon. 2024 Aug;70(8):101753. doi: 10.1016/j.disamonth.2024.101753. Epub 2024 Jun 21. Dis Mon. 2024. PMID: 38908985 Review.
Cited by
-
Other dementias.Neuroradiology. 2011 Sep;53 Suppl 1:S149-60. doi: 10.1007/s00234-011-0932-5. Neuroradiology. 2011. PMID: 21863422 Review. No abstract available.
-
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review.Neurol Ther. 2024 Aug;13(4):975-1013. doi: 10.1007/s40120-024-00614-9. Epub 2024 May 14. Neurol Ther. 2024. PMID: 38743312 Free PMC article. Review.
-
Progressive supranuclear palsy: Advances in diagnosis and management.Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25. Parkinsonism Relat Disord. 2020. PMID: 32487421 Free PMC article. Review.
-
Magnetic resonance imaging in progressive supranuclear palsy.J Neurol. 2011 Apr;258(4):549-58. doi: 10.1007/s00415-010-5865-0. Epub 2010 Dec 22. J Neurol. 2011. PMID: 21181185
-
Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.Neurotherapeutics. 2021 Apr;18(2):728-752. doi: 10.1007/s13311-021-01101-x. Epub 2021 Aug 13. Neurotherapeutics. 2021. PMID: 34389969 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous